Author:
Johnston Stephen R.D.,Dowsett Mitch
Publisher
Springer Science and Business Media LLC
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference98 articles.
1. Early Breast Cancer Trialist Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351, 1451–1467 (1998).
2. Peto, R., Boreham, J., Clarke, M., Davies, C. & Beral, V. UK and USA breast cancer deaths down 25% in year 2000 at ages 29–60 years. Lancet 355, 1822 (2000).
3. Cuzick, J. et al. Overview of the main outcomes in breast cancer prevention trials. Lancet 361, 296–300 (2003).
4. McDonnell, D. P. & Connor, C. E., Wijayaratne, A., Chang, C. Y. & Norris, J. D. Definition of the molecular and cellular mechanisms underlying the tissue-selective agonist/antagonist activities of selective estrogen receptor modulators. Recent Prog. Horm. Res. 57, 295–316 (2002).
5. Girault, I. et al. Expression analysis of estrogen receptor α coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen. Clin. Cancer Res. 9, 1259–1266 (2003).
Cited by
254 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献